Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Experimental autoimmune encephalomyelitis (EAE) is a model for multiple sclerosis (MS).
• Understanding the temporal relationship between inflammation, axon damage, and functional deficits is crucial for MS.
• Myelin oligodendrocyte glycoprotein (MOG) peptide is a common EAE induction agent.

Purpose of the Study:

• To investigate the early pathological changes in MOG-induced EAE.
• To correlate inflammatory and neural markers with behavioral outcomes over time.
• To identify therapeutic windows for neuroprotection in MS.

Main Methods:

• Induction of EAE in a rodent model using MOG peptide.
• Longitudinal measurement of inflammatory (T cell infiltration, microglial activation) and neural (axon loss) markers.
• Assessment of behavioral deficits (EAE scores, rotarod, grip strength).
• Ultrastructural analysis for remyelination detection.

Main Results:

• Axon loss was detectable before overt behavioral signs and subtle inflammatory cell infiltration.
• Remyelination was observed only at the ultrastructural level.
• Axon numbers stabilized around 30 days post-immunization.
• Behavioral recovery was only partial despite axon number stabilization.

Conclusions:

• Axon degeneration in EAE initiates before clinical manifestation and minimal inflammation.
• Early neuroprotection strategies may be necessary to prevent irreversible axon damage in MS.
• This study provides a temporal framework for evaluating neuroprotective therapies in MS models.